TY - JOUR
T1 - Glycemic Responses to Graded Exercise Testing in Adolescents Using Automated Insulin Delivery Systems
AU - Lindkvist, Emilie Bundgaard
AU - McCarthy, Olivia Mary
AU - Tawfik, Sandra
AU - Zaucha Sørensen, Michael
AU - Bracken, Richard
AU - Ranjan, Ajenthen G
AU - Svensson, Jannet
AU - Nørgaard, Kirsten
PY - 2025/11/7
Y1 - 2025/11/7
N2 - This study evaluated the glycemic responses to a graded exercise test (GXT) performed by 24 adolescents with type 1 diabetes (T1D) using automated insulin delivery (AID) systems. Each participant partook in a GXT on a bicycle ergometer until volitional exhaustion. Plasma glucose and lactate levels were measured during the GXT, whereas sensor glucose was monitored in the hours thereafter. Plasma glucose levels were stable throughout the GXT (overall change of -0.26 mmol/L [-5 mg/dL], P = 0.593), with no hypoglycemic events. Sensor glucose levels also remained stable and within the recommended glucose target ranges after the GXT for the remaining day and night, with only a few episodes of mild hypoglycemia. This study highlights the glycemic safety of performing GXT for adolescents utilizing AID systems.
AB - This study evaluated the glycemic responses to a graded exercise test (GXT) performed by 24 adolescents with type 1 diabetes (T1D) using automated insulin delivery (AID) systems. Each participant partook in a GXT on a bicycle ergometer until volitional exhaustion. Plasma glucose and lactate levels were measured during the GXT, whereas sensor glucose was monitored in the hours thereafter. Plasma glucose levels were stable throughout the GXT (overall change of -0.26 mmol/L [-5 mg/dL], P = 0.593), with no hypoglycemic events. Sensor glucose levels also remained stable and within the recommended glucose target ranges after the GXT for the remaining day and night, with only a few episodes of mild hypoglycemia. This study highlights the glycemic safety of performing GXT for adolescents utilizing AID systems.
U2 - 10.1177/15209156251390834
DO - 10.1177/15209156251390834
M3 - Journal article
C2 - 41203257
SN - 1520-9156
JO - Diabetes Technology & Therapeutics
JF - Diabetes Technology & Therapeutics
ER -